Summary of Expertise, Experience, and Affiliations and Interests - Paediatric Expert Advisory Committee (PEAC)

Purpose

The following table summarizes the information about expertise, experience, and affiliations and interests relevant to the Paediatric Expert Advisory Committee mandate declared by committee members. Health Canada considered these declarations as part of the selection process. The Health Products and Food Branch has made this summary available as part of its commitment to be transparent about the membership of its advisory bodies.

Assessment of affiliations and interests prior to each meeting

Prior to each committee meeting, the Health Products and Food Branch assesses members' affiliations and interests, including direct financial interests, as they may apply to agenda items for discussion. Depending on the nature of the member's affiliations and interests, the Branch, or the chair of the committee in consultation with the Branch, may limit the participation of a member in the meeting or ask him/her to make a verbal statement of affiliations and interests at the beginning of the meeting. Members' affiliations and interests are reviewed on an annual basis and updated as required based on changes in the status of their affiliations and interests.

In accordance with the Health Products and Food Branch Review of Regulated Products: Policy on Public Input and Guidance on Advisory Bodies, a person with a direct financial interest in the outcome of a review of a regulated product may be a member of an advisory body whose broader mandate encompasses matters of policy, management, or program development. However, such a member would not be asked to participate in any discussion, formulation of advice, or recommendations to the Branch relating to that review.

Indicated Sector/Perspective and Expertise/Experience

Sector/perspective:

  • Consumer Group
  • Disease Group
  • Hospital
  • Industry
  • Non-Governmental Organization
  • Patient Group
  • Research Institute
  • University
  • Voluntary Sector
  • Other

Expertise/experience:

  • Bio-medical Ethics
  • Children's Health Organizations
  • Children's Hospitals
  • Clinical Pharmacology
  • Community Care
  • Complementary/Alternative Medicine
  • Epidemiology
  • Family Medicine   
  • Food Science
  • Immunology
  • Nutrition/Diet
  • Parents/Consumer
  • Paediatric Medicine
  • Paediatric Nursing
  • Paediatric Patient Safety
  • Paediatric Specialty Care
  • Paediatric Surgery
  • Pharmacy Practice
  • Research Decision-Making
  • Population Health
  • Toxicology
  • Other (Please specify)

1. Direct financial interests

  1. Current employment, investments in companies, partnerships, equity, royalties, joint ventures, trusts, real property, stocks, shares, or bonds with the regulated industry.

2. Indirect financial interests

  1. Within the past five years, payment from the regulated industry for work done or being done, including past employment, contracts, or consulting; or financial support including research support, personal education grants, contributions, fellowships, sponsorships, and honoraria.Footnote 1
  2. Within the past five years, materials, discounted products, gifts, or other benefits, or attendance at meetings where all or part of the travel and accommodation costs were provided by the regulated industry.Footnote 2
  3. Within the last three years, grants or other funding from the regulated industry to any of the organizations where you are currently employed or participate in internal decision making.Footnote 3

3. Intellectual interests

  1. Within the last five years, any formal advice or opinion to industry, a government organization, or a non-government organization.
  2. Within the last five years, any published or publicly stated point of view.
  3. Current professional or volunteer affiliations such as membership of professional societies, lobbying, public interest, or advocacy groups.

4. Other

  1. Any other affiliations and interests or potential circumstances that might give a well-informed member of the public reasonable grounds for concern regarding the integrity and objectivity of your participation.

Summary of Expertise, Experience, and Affiliations and Interests

Noni MacDonald

Hospital, NGO, Research Institute, University, Epidemiology, Paediatrics, Research Decision Making, Population Health, Chronic Disease, Health Policy, Infectious Disease, International Health (WHO), Virology, Communications

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. Yes
  • 3b. Yes
  • 3c.Yes
  • 4a. No

Comments: Member of Expert Advisory Committees: Blood Regulation (Health Canada); Cells Tissues and Organs (HC); Advisory Council National Collaborating Centers for Public Health (PHAC) and Professor in the Department of Paediatrics at Dalhousie University. Board Member: Canadian Paediatric Society. Board Member: Canadian Academic Health Science, Board Member Brunswick St. Mission. Consultant for Vaccine Safety, Department of Immunization, Vaccines and Biologicals, World Health Organization. Co-editor in Chief, Paediatrics and Child Health Journal and Section Editor, Public Health, Canadian Medical Association Journal (CMAJ).

Mary Lye

Voluntary Sector, Patient/Consumer, Disease Group

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. No
  • 4a. No

Comments: None.

Ellen Tsai

Hospital, University Intensive Care, Biomedical Ethics, Epidemiology, Paediatrics, Paediatric Patient Safety, Research Decision Making, Paediatric Patient

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. Yes
  • 4a. No

Comments: Member of the Canadian Paediatric Society.

Max Coppes

Hospital, Paediatric Specialty Care (Hematology), Toxicology (Oncology), Patient safety

Summary of Responses

  • 1a. No
  • 2a. Yes
  • 2b. No
  • 2c. Yes
  • 3a. No
  • 3b. Yes
  • 3c. Yes
  • 4a. No.

Comments: Senior Vice President responsible for the Center for Cancer and Blood Disorders and Director Center for Cancer and Immunology Research at Children's National Medical Center, Washington, DC. Consultant for Eisai and Astellas Pharma US Inc. Senior leader in pediatric oncology, senior leader of large US children's hospital and has made many public statements directly related to child health care. Editor Board (chief Childhood Cancers section) Hematology/Oncology Today; Editor-in-Chief, Pediatric Oncology, eMedicine World Medical Library; Editor-in-Chief, Pediatric Hematology eMedicine World Medical ,Associate Editor Pediatric Blood and Cancer, and member of editorial board, Journal of Pediatric Hematology/Oncology. Member of American Society for Clinical Oncology, American Society of Pediatric Hematology/Oncology, International Society of Paediatric Oncology, Society for Pediatric Research, Sociedad Latinoamericana de Oncologia Pediátrica, Children's Oncology Group, Société Française d'Oncologie Pédiatrique, American Association for Cancer Research. Medical Advisor of the Dutch Quality of Life Gala foundation.

Gideon Koren

Children's hospital, Maternal Health, Children's Health Organizations, Paediatric Medicine, Clinical Pharmacology, Toxicology/Oncology, Research Decision-Making.

Summary of Responses

  • 1a. No
  • 2a. Yes
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. No
  • 4a. No

Comments: Consultant for Duchesnay Inc. and Novartis.

Robin Walker

Hospital, Research Institute
Paediatric Specialty: Neonatology, Research Decision Making

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. Yes
  • 3b. Yes
  • 3c. Yes
  • 4a. No

Comments: Board Member of Canadian Institute and Child Health. Member: Canadian Paediatric Society; Canadian Association of Physicians for the Environment and American Academy of Pediatrics. Served on Federal Advisory Committees (Health Canada) and committees of the Canadian Paediatric Society, Canadian Institute of Child and Health and American Academy of Pediatrics. Author of various publications on neonatal: journals, books, papers, research and reports.

L. Lee Dupuis

Children's Hospital, University, Clinical Pharmacology, Pharmacy Practice, Specialty: Paediatric Pharmacy and Oncology

Summary of Responses

  • 1a. No
  • 2a. Yes
  • 2b. No
  • 2c. Yes
  • 3a. Yes
  • 3b. Yes
  • 3c. Yes
  • 4a. No

Comments: Received honorarium from GlaxoSmithKline as member of Pediatric Advisory Board. Member of The Hospital for Sick Children (Sickkids) staff who received grants from regulated industry. Provided formal advice/opinions to: Canadian Pharmacists Association, CPS Editorial Advisory Panel, Paediatric Oncology Group of Ontario and PHAC Roundtable on the Issue of Children Living with Cancer. Member of Canadian Society of Hospital Pharmacists, American College of Clinical Pharmacy, Paediatric Oncology Group of Ontario, C17 Standards & Guidelines Committee (co-chair), CPAC Cancer Guidelines Action Group and Children's Oncology group. Associate editor of Canadian Journal of Hospital Pharmacy. Author of various editorials and publications regarding pharmacy practice, pediatric pharmacotherapy and supportive care of children with cancer.

Lorella Garofalo

Industry, Bio-medical Ethics Clinical Pharmacology Research Decision-Making Paediatric Clinical Trials

Summary of Responses

  • 1a. Yes
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. No
  • 4a. No

Comments: Shareholder and employee, Pfizer Canada Inc.

Patricia Rennie

NGO, College Alternative Medicine, Nutrition, Paediatrics, Private Practice ( Family Medicine)

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. No
  • 4a. No

Comments: None

Stephanie Atkinson

Hospital Research Institute University Paediatric Specialty: Nutrition, Research Decision Making, Chronic Disease.

Summary of Responses

  • 1a. No
  • 2a. Yes
  • 2b. Yes
  • 2c. Yes
  • 3a. Yes
  • 3b. Yes
  • 3c. Yes
  • 4a. No

Comments: Speaker/consultant for Wyeth Nutrition International, Nestle Nutrition Canada and Mead Johnson. Received in-kind research materials from Eli Lilly, Wyeth Consumer Healthcare Inc, CAN. Provided formal advice/opinions to Health Canada, WHO/FAO/UNU, International Atomic Energy Agency, Food and Nutrition Board, Institute of Medicine and Dieticians of Canada. Commissioned paper by Dieticians of Canada- Vitamin D: Current Dilemmas. Member: American Society for Nutrition, American Society for Bone and Mineral Research, Canadian Society for Nutritional Sciences, The Hospital for Sick Children (SickKids) Grants Advisory Committee and is on the Board of Trustees for Friends of Canadian Institutes for Health Research, the International Life Sciences Institute of North America and Scientific Advisory Council for Osteoporosis Canada. 

Patricia Ann Malloy

Children's Hospitals Paediatric Patient Safety, Paediatric Nursing Aboriginal Health Infectious Diseases

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. Yes
  • 3b. No
  • 3c. No
  • 4a. No

Comments: Co-author of Paediatric Chapter in the current edition of the Canadian Tuberculosis Standards.

Laurie Proulx

Consumer Group Patient Group NGO Chronic Disease

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. No
  • 3a. No
  • 3b. No
  • 3c. Yes
  • 4a. No

Comments: Steering Committee Member and Chair, Childhood Arthritis Committee, Canadian  Arthritis Patient Alliance, Presentations made to Health Canada's Cox-2 Public Forum and Expert Advisory Committee on the Vigilance of Health Products

Stuart MacLeod

Hospital, Research Institute, University, Clinical Pharmacology Epidemiology, Paediatrics, Paediatric Patient Safety, Research Decision Making, Population Health, Toxicology, Environmental and International Health

Summary of Responses

  • 1a. No
  • 2a. Yes
  • 2b. No
  • 2c. Yes
  • 3a. Yes
  • 3b. Yes
  • 3c. Yes
  • 4a. No

Comments: Received honorarium from Lilly as Chair of a Scientific Advisory Committee in 2008. Participant during past 5 years in educational and scientific meetings sponsored by Pfizer, Merck Frost, Lilly, Wyeth, Genzyme and Bayer. Executive director of the Child and Family Research Institute at British Columbia Children's Hospital and Associate Dean University of British Columbia Faculty of Medicine and oversees research contracts with private sector. Has provided medicolegal advice through third parties to Shire Pharmaceuticals and Janssen-Ortho Inc. re treatment of attention deficit disorder. Provided advice to Health Canada- on Adderal and serves on Advisory Committee to Health Products and Food Branch, National Institute of Child Health and Human Development, and World Health Organization's Better Medicines for Children. Various presentations on paediatric drug therapy and author of a number of publications on pharmacology; books, journals and articles. Past President of Canadian Society for Clinical Pharmacology; member of Research Canada and technical advisor to a World Health Organization Expert Advisory Committee designing an essential medicines list for children.

Gary Pekeles

Hospital, NGO, University, First Nations Health, Community Care, Epidemiology, Paediatrics, Research Decision Making, Population Health, Health Policy.

Summary of Responses

  • 1a. No
  • 2a. No
  • 2b. No
  • 2c. Yes
  • 3a. Yes
  • 3b. Yes
  • 3c. Yes
  • 4a. No

Comments: Canadian Paediatric Society (CPS) received unrestricted grants for activity decided upon, vetted and carried out by CPS in a completely independent fashion.Provided formal advice to Ministère de la Santé et des Services sociaux (MSSS) Québec. Provided commentaries for the journal of Paediatrics and Child Health.Member of the Board of Governors, at McGill University and Canadian Paediatric Society.  Advocates broader public funding for childhood vaccines.

Page details

Date modified: